Reverse dilation with just 1-2 drops1
Order NowOffer the only commercially available FDA‑approved product that reverses dilation.1-3
One single-patient-use vial should be dispensed for each patient, and it can be used to dose both eyes. Discard the single‑patient‑use vial immediately after use.1
PATIENTS AGED 12 YEARS AND OLDER1
1-2 drops
- Instill 1 or 2 drops in each dilated eye following the completion of the ophthalmic examination or procedure
- If 2 drops are instilled, the second drop should be administered 5 minutes after the first drop
PATIENTS AGED
3‑11 YEARS1
1 drop
- Instill 1 drop in each dilated eye following the completion of the ophthalmic examination or procedure
The efficacy of RYZUMVI was similar for all age ranges, including pediatric subjects aged 3 to 17 years. Pediatric subjects aged 12 to 17 years (n=27) were treated in MIRA-2 and MIRA-3, and pediatric subjects aged 3 to 11 years (n=11) were treated in MIRA‑4.1
As an eye care professional, the decision to use one or two drops of RYZUMVI is based on your discretion and judgment.
How RYZUMVI is supplied
RYZUMVI is a sterile, clear, and colorless topical ophthalmic solution and comes in a translucent, low-density polyethylene, single‑patient‑use vial (0.31 mL fill).1 Does not contain an antimicrobial preservative. Stable topical eye drops are available in a single-patient-use vial, with no mixing required.
PACKAGING1
- Each carton contains 30 single-patient-use vials of RYZUMVI
- One strip of 5 single-patient-use vials is packaged into a foil pouch, with 6 foil pouches in a carton
Storage & refrigeration1
- Store refrigerated at 2°C to 8°C (36°F to 46°F), not to exceed the expiration date printed on the carton and pouch
- Protect from freezing
- After opening the foil pouch, the product may be stored at 25°C (68°F to 77°F) and should be used within 14 days, not to exceed the expiration date printed on the vial
- The single‑patient‑use vial once opened should be discarded immediately after use
